Arax Advisory Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Sell |
|
|||||
|
2025
Q1 | $14.4K | Sell |
|
|||||
|
2024
Q4 | $72.9K | Sell |
|
|||||
|
2024
Q3 | $90.1K | Hold |
|
|||||
|
2024
Q2 | $108K | Buy |
|
|||||
|
2024
Q1 | $5.93K | Hold |
|
|||||
|
2023
Q4 | $5.67K | Sell |
|
|||||
|
2023
Q3 | $5.18K | Buy |
|
|||||
|
2023
Q2 | $3.49K | Sell |
|
|||||
|
2023
Q1 | $4.66K | Hold |
|
|||||
|
2022
Q4 | $5.49K | Hold |
|
|||||
|
2022
Q3 | $5K | Buy |
|
|||||
|
2022
Q2 | $4K | Hold |
|
|||||
|
2022
Q1 | $3K | Buy |
|